PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.00 - 0.01
0.00 - 0.02
289 / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
100.00%
Revenue growth of 100.00% while ECL.AX is flat. Bruce Berkowitz would check if a small edge can widen further.
-45.66%
Negative gross profit growth while ECL.AX is at 0.00%. Joel Greenblatt would examine cost competitiveness or demand decline.
-92.42%
Negative EBIT growth while ECL.AX is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-92.42%
Negative operating income growth while ECL.AX is at 0.00%. Joel Greenblatt would press for urgent turnaround measures.
100.00%
Net income growth of 100.00% while ECL.AX is zero. Bruce Berkowitz would see if small gains can accelerate into a larger gap.
200.00%
EPS growth of 200.00% while ECL.AX is zero. Bruce Berkowitz would see if minimal gains can accelerate over time.
50.00%
Diluted EPS growth of 50.00% while ECL.AX is zero. Bruce Berkowitz would see if minimal gains can be scaled further for a bigger lead.
2.52%
Share change of 2.52% while ECL.AX is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
2.52%
Diluted share change of 2.52% while ECL.AX is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative OCF growth while ECL.AX is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-100.00%
Negative FCF growth while ECL.AX is at 0.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
131.31%
Positive 10Y revenue/share CAGR while ECL.AX is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
329.11%
Positive 5Y CAGR while ECL.AX is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
39.95%
Positive 3Y CAGR while ECL.AX is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
-102513.07%
Negative 10Y OCF/share CAGR while ECL.AX stands at 179.16%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-807.57%
Negative 5Y OCF/share CAGR while ECL.AX is at 270.02%. Joel Greenblatt would question the firm’s operational model or cost structure.
-188.10%
Negative 3Y OCF/share CAGR while ECL.AX stands at 18.61%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
24856.74%
Positive 10Y CAGR while ECL.AX is negative. John Neff might see a substantial advantage in bottom-line trajectory.
1928.87%
Positive 5Y CAGR while ECL.AX is negative. John Neff might view this as a strong mid-term relative advantage.
-26.66%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
94.41%
5Y equity/share CAGR above 1.5x ECL.AX's 42.75%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
52.28%
3Y equity/share CAGR above 1.5x ECL.AX's 30.98%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-2.46%
We have a declining book value while ECL.AX shows 0.00%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
8.96%
Debt growth of 8.96% while ECL.AX is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
No Data
No Data available this quarter, please select a different quarter.
-32.55%
We cut SG&A while ECL.AX invests at 0.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.